Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Product: Terazosin hydrochloride (Antihypertensive)
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Terazosin 2mg tablets
0205040V0AAABAB
|
Terazosin hydrochloride (Antihypertensive) | Terazosin hydrochloride | Cardiovascular System | 4,179 |
|
Terazosin 10mg tablets
0205040V0AAADAD
|
Terazosin hydrochloride (Antihypertensive) | Terazosin hydrochloride | Cardiovascular System | 4,029 |
|
Terazosin 5mg tablets
0205040V0AAACAC
|
Terazosin hydrochloride (Antihypertensive) | Terazosin hydrochloride | Cardiovascular System | 3,024 |
|
Terazosin 2mg tablets and Terazosin 1mg tablets
0205040V0AAAAAA
|
Terazosin hydrochloride (Antihypertensive) | Terazosin hydrochloride | Cardiovascular System | 23 |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.